Radar HealthTech | Sdli
  • Sdli
  • Nuestros Clientes
  • Nuestro equipo
  • Radar Sdli
  • Blog Sdli
  • Escríbenos!
Seleccionar página
AstraZeneca’s new AI, Milton, promises to predict over a thousand diseases before diagnosis

AstraZeneca’s new AI, Milton, promises to predict over a thousand diseases before diagnosis

por Sdli Scouter | Sep 19, 2024 | Sin categoría

Traditional drug development has long relied on hypothesis-driven approaches. This method involves pinpointing specific targets and mechanisms through preclinical studies, but often grapples with uncertainties regarding the translatability of these findings to...
A digital therapy shows success in reducing migraine days

A digital therapy shows success in reducing migraine days

por Sdli Scouter | Sep 19, 2024 | Health Management

Migraine is a complex and debilitating condition that affects more than 47 million Americans,1 and is the second leading cause of years lived with a disability.2 For those living with migraine, attacks unfold over hours to days and negatively impact many domains...
A voice-based app could revolutionize early detection and management of depression trough voice

A voice-based app could revolutionize early detection and management of depression trough voice

por Sdli Scouter | Sep 19, 2024 | Health Management

Depression, which affects over 258 million people globally, is not just an emotional struggle; it’s a leading cause of disability and lost productivity. Traditional screening methods, such as questionnaires, often fall short in accurately assessing the depth of...

Rapid UTI test cuts detection time from 3 days to 45 minutes

por Sdli Scouter | Sep 12, 2024 | Diagnostic Tools

In a groundbreaking development for diagnostic medicine, a recent clinical study has validated the Sysmex PA-100 AST system’s effectiveness in detecting bacteriuria—bacteria in the urine—and performing antimicrobial susceptibility tests (AST) within just 45...
First of it’s kind ‘ChemoPatch’ to stop pancreatic cancer returning

First of it’s kind ‘ChemoPatch’ to stop pancreatic cancer returning

por Sdli Scouter | Sep 12, 2024 | Health Management, Prevention

Pancreatic cancer is notorious for its low survival rate, with fewer than 7% of patients surviving beyond five years in the UK. Surgery remains the only potentially curative option, but about 75% of patients experience recurrence. Current chemotherapy treatments often...
« Entradas más antiguas
Entradas siguientes »

© -2026 | Sdli